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Abstract
IMPORTANCE TheModular Approach to Therapy for Children (MATCH) was developed to address
the comorbidities common among clinically referred youth, with beneficial outcomes shown in 2 US
randomized clinical trials, where it outperformed both usual clinical care and single disorder–
specific treatments.
OBJECTIVE To determine whether MATCH training of clinicians would result in more use of
empirically supported treatment (EST) and better clinical outcomes than usual care (UC) in the
publicly funded, multidisciplinary context of New Zealand.
DESIGN, SETTING, ANDPARTICIPANTS This multisite, single-blind, computer-randomized clinical
effectiveness trial compared MATCH with UC in child and adolescent mental health services in 5
regions of New Zealand. Recruitment occurred fromMarch 2014 to July 2015, and a 3-month
follow-up assessment was completed by May 2016. Clinicians at participating child and adolescent
mental health services were randomized (1:1) to undertake training in MATCH or to deliver UC, and
young people with anxiety, depression, trauma-related symptoms, or disruptive behavior seeking
treatment at child and adolescent mental health services were randomized (1:1) to receive MATCH or
UC. Participants and research assistants were blind to allocation. Data analysis was performed from
April 2016 to July 2017.
INTERVENTIONS MATCH comprises EST components for flexible management of commonmental
health problems. UC includes case management and psychological therapies. Both can include
pharmacotherapy.
MAINOUTCOMES ANDMEASURES There were 3 primary outcomes: trajectory of change of
clinical severity, as measured by weekly ratings on the Brief ProblemMonitor (BPM); fidelity to EST
content, as measured by audio recordings of therapy sessions coded using the Therapy Integrity in
Evidence Based Interventions: Observational Coding System; and efficiency of service delivery, as
measured by duration of therapy (days) and clinician time (minutes).
RESULTS The study included 65 clinicians (mean age, 38.7 years; range, 23.0-64.0 years; 54 female
[83%]; MATCH, 32 clinicians; UC, 33 clinicians) and 206 young people (mean age, 11.2 years; range
7.0-14.0 years; 122 female [61%]; MATCH, 102 patients; UC, 104 patients). For the BPM total ratings
for parents, there was a mean (SE) slope of –1.04 (0.14) (1-year change, −6.12) in theMATCH group vs
–1.04 (0.10) (1-year change, −6.17) in the UC group (effect size, 0.00; 95%CI, −0.27 to 0.28; P = .96).
For the BPM total for youths, the mean (SE) slope was –0.74 (0.15) (1-year change, −4.35) in the
MATCH group vs –0.73 (0.10) (1-year change, −4.32) in the UC group (effect size, −0.02; 95% CI,
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Abstract (continued)
−0.30 to 0.26; P = .97). Primary analyses (intention-to-treat) showed no difference in clinical
outcomes or efficiency despite significantly higher fidelity to EST content in the MATCH group (58
coded sessions; mean [SD], 80.0% [20.0%]) than the UC group (51 coded sessions; mean [SD],
57.0% [32.0%]; F(1,108) = 23.0; P < .001). With regard to efficiency of service delivery, there were no
differences in total face-to-face clinician time between the MATCH group (mean [SD], 806 [527]
minutes) and the UC group (mean [SD], 677 [539] minutes) or the overall duration of therapy
between theMATCH group (mean [SD], 167 [107 days]) and the UC group (mean [SD], 159
[107] days).
CONCLUSIONS AND RELEVANCE MATCH significantly increased adherence to EST practices but
did not improve outcomes or efficiency. The nonsuperiority of MATCHmay be attributable to high
levels of EST use in UC in New Zealand.
TRIAL REGISTRATION Australian New Zealand Clinical Trials Registry Identifier:
ACTRN12614000297628
JAMA Network Open. 2020;3(8):e2011799. doi:10.1001/jamanetworkopen.2020.11799
Introduction
Mental health problems in children and adolescents are common and persistent.1,2 There are
effective therapies available3; however, delivering these therapies in clinical practice has been
challenging.4 This is partly because the evidence is primarily available for single disorders or a
homogeneous cluster of problems,5 whereas clinicians are faced with comorbid presentations that
may change in focus during therapy. Clinicians may adopt a pragmatic but eclectic approach,
unintentionally eroding the impact of carefully designed best clinical practice. TheModular Approach
to Therapy for Children with Anxiety, Depression, Trauma, or Conduct Problems (MATCH-ADTC or
MATCH, for brevity) has been designed to address the issues of flexibility and clinical complexity after
a brief but comprehensive training program and has been shown to bemore effective and efficient
than usual care (UC).6,7
In New Zealand, preregistration courses for mental health professionals do not include in-depth
training in psychological therapies for children and adolescents.8 For many working in child and
adolescent mental health services (CAMHS), training in empirically supported treatments (ESTs), if it
occurs, takes place after qualifying, either informally on the job or in courses that are time-
consuming. Although there have been efforts to roll out training in ESTs in New Zealand, this is
piecemeal so that having consistent delivery of ESTs is challenging.
We sought to determine whether training in MATCH could improve UC in New Zealand as it had
been shown to do in studies in the US. Our primary hypotheses were that training CAMHS clinicians
in MATCH, compared with UC, would increase the delivery of ESTs, improve clinical outcomes, and
yield equal or better efficiency of service delivery.
Methods
The study protocol has been published elsewhere9 and is available in Supplement 1. This study was
approved by New Zealand’s Health and Disability Ethics Committee and was overseen by a Data
Monitoring Committee of the Health Research Council of New Zealand. Participants providedwritten
informed consent. This study follows the Consolidated Standards of Reporting Trials (CONSORT)
reporting guideline.
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Trial Design
We performed amultisite, single-blind, randomized clinical effectiveness trial comparing MATCH
with UC in CAMHS in 5 District Health Boards in New Zealand. In New Zealand, 20 District Health
Boards are responsible for funding or providing health services within their district or geographical
region. Participating teams in the District Health Boards provided services in rural and urban settings
and included 1 KaupapaMāori and 2 Pacific teams. KaupapaMāori teams are those in which the
philosophical doctrine incorporates the knowledge, skills, attitudes, and values of Māori (ie,
Indigenous) society. Pacific teams are those in which people originating from other Pacific Islands are
seen in services designed to incorporate the knowledge, skills, attitudes, and values of Pasifika
societies.
Datawere collected at baseline, during treatment, and 3months after the end of treatment. The
recruitment period was March 2014 to July 2015, with follow-up completed in May 2016.
Randomization, Blinding, andAllocation Concealment
Randomization was at 2 levels: first, clinicians were randomized in a 1:1 ratio stratified by service or
team to undertake training in MATCH at the start or at the completion of the study; and second,
young people and their families were randomized in a 1:1 ratio stratified by sex and ethnicity (Māori,
Pacific, or an other ethnicity) to receive MATCH or UC. The major ethnic groups in New Zealand
includeMāori, the Indigenous people of New Zealand (14.9% of the population), New Zealand
European people (74% of the population), Asian people (11.8% of the population), and non-Māori
Pacific people (7.4%of the population) who have settled in New Zealand from the Pacific Islands such
as Samoa. Inequities in the health andmental health forMāori and Pacific people have led to specific
mental health services being set up in some regions to attempt to reduce the inequities. However,
manyMāori and Pacific young people are seen in themainstream CAMHS.
Electronically generated randomization sequences ensured allocation concealment. Young
people, their families, and the research assistants collecting data were blind to allocation.
Participants
Inclusion and Exclusion Criteria for the Clinicians
Clinicians were eligible if they provided clinical treatment to young people and their families at
participating CAMHS and provided written, informed consent. They were invited to take part in the
study by their service manager.
Inclusion and Exclusion Criteria for the Young People
English-speaking young people, aged 7 to 14 years, referred to CAMHSwith a primary presenting
problem that included anxiety, depression, trauma-related symptoms, or disruptive behavior were
eligible for the study. Families were invited to take part in the study by the intake clinician and were
included if parents providedwritten, informed consent and the young person assented. Youthwere
excluded if they were already being treated, the primary focus of treatment was for another disorder
or problem, or a sibling had already been recruited into the study.
Setting
CAMHS providemental health care for young people aged 0 to 19 years.10 CAMHS are organized into
multidisciplinary teams of registered health practitioners, primarily nurses with training in mental
health and social workers.11
Interventions
MATCH
MATCH is a manualized program of 33modules addressing 4 problem domains commonly
encountered in clinical practice.12 MATCH combines written resources, a framework for choice of
intervention, and guidance from an online system for monitoring progress and providing timely
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feedback to clinicians. It combines empirically supported elements of existing therapies within 1
protocol and accommodates comorbidity and changes in clinical presentation during therapy.13
Therapists randomized to deliver MATCHwere provided with 5 days’ training and then 1-hour
weekly Skype-based group consultation (mean [SD] group size, 4 [1.4] individuals; range, 2-6
individuals) provided byMATCH experts (A.M.U., S.K.B., and J.H.). At the start of treatment, the
young person and their family collaboratively established the top problems to be addressed.14
Clinicians used these problems to tailor treatment. Pharmacotherapy was used as part of standard
CAMHS practice, as in UC.
Usual Care
Usual care includes case management, psychological therapies, and pharmacotherapy. UC is
overseen in multidisciplinary teammeetings, typically focused on brief reviews and care
coordination.
Outcomes
Demographic information was provided by parents at enrollment in the study. Because of disparities
in mental health outcomes for Māori and Pacific people in New Zealand, ethnicity data were
collected.
Research assistants who were blinded to participant treatment group collectedmost clinical
measures by telephone. Additional data were collected from clinicians after the participants had
been discharged.
PrimaryOutcomes
In keeping with the primary hypotheses, there were 3 primary outcomes. First, the trajectory of
change of clinical severity was assessed using the parent-rated Brief ProblemMonitor (BPM)15
administered weekly. Second, the fidelity (ie, adherence and competence) with which therapists
used EST content12 was measured from audio recordings of therapy sessions using themethods and
coding system adapted from those used in the initial trial of MATCH.16 Therapist competence was
rated as follows: 0, not at all; 1, superficial or incomplete; 2, adequate but not optimal; 3, thorough;
and 4, expert. Ten percent of recorded therapy sessions (MATCH and UC) were assessed by the
research coding team (blind to treatment group). Ten percent of this sample were independently
double-coded and had acceptable interrater agreement (mean intraclass correlation coefficient [ICC]
on adherence, 0.70; mean ICC on competence, 0.67). Because the results of our initial coding of
therapy sessions of UC were markedly different from those of previous studies,6,7 we conducted a
second round of coding with a subset of 100 randomly selected sessions, coded by experienced
independent coders from the US, with 20%of this sample independently assessed by a coder in New
Zealand to check for systematic discrepancies between countries. The interrater agreement was
acceptable across US and New Zealand coders for adherence (mean ICC, 0.74) and competence
(mean ICC, 0.73). Third, the efficiency of service delivery (extracted from logs completed by
clinicians) was assessed using duration of therapy (days), clinician time (minutes), and the number of
therapy sessions attended andmissed.
SecondaryOutcomes
Secondary outcomes included the youth-rated BPM administered weekly,15 the parent- and youth-
rated Strengths and Difficulties Questionnaire administered monthly,17 the parent- and youth-rated
Top Problems Assessment administeredweekly,14 the Child Health Utility (a quality of life assessment
administered at baseline, discharge, and follow-up),18 and the number and type of diagnoses
assessed at baseline and discharge using the Development andWell-Being Assessment.19 Prescribed
medications were recorded at baseline, discharge, and follow-up. Clinician satisfaction with therapy
was assessed using the Therapist Satisfaction Index.20 A treatment satisfaction questionnaire for
parents and youth was developed for this study.
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Measures of Harm
Reports of serious adverse events9 were collected and reported to the Data Monitoring Committee.
At the request of the Data Monitoring Committee, we developed a measure for moderate adverse
events that were reported during the study and collected from the parents through specific enquiry
at follow-up.
Sample Size and Power
Details of the initial sample size and changes to it have been published elsewhere.9 From the results
of previous studies,7 we estimated that 200 participants would be needed for 90%power to detect
a significant difference in the change that was clinically important (ie, >2 units, with an effect size of
approximately 0.45) on the parent BPM change (2-tailed α = .05).
Statistical Analysis
The primary analyses used the intention-to-treat population. Because neither MATCH nor UC has a
fixed duration, testing of the primary clinical hypothesis compared the trajectory of change across
time on the parent-rated BPM (total score) as per the original studies.6,7 A mixed-effects regression
model was used, with outcome = a0(intercept) + a1(treatment group) + a2(time) + a3(treatment ×
time), with treatment and time (loge day) treated as fixed effects and the participant intercepts and
slopes as random events. Sensitivity analyses were performed to test for the consistency of
treatment response across medication use, clinician site, and previous evidence-based therapy
training categories, by testing the appropriate interaction terms. Per-protocol analyses included
participants who completed the study, received therapy as per their allocated treatment group, and
had completed at least 4 therapy sessions. For the second and third primary hypotheses and all
treatment satisfactionmeasures, between-group comparisons were made using univariable ANOVA.
Trajectories of change for secondary clinical outcomes were compared for the Strengths and
Difficulties Questionnaire and Top Problems Assessment as described previously in this article.
Changes in the Child Health Utility were compared between groups using univariable ANOVA to
assess changes between baseline, discharge, and at 3-month follow-up. Two-tailed P < .05 was
considered to indicate statistical significance. Data analysis was performed using SPSS statistical
software version 25 (IBM Corp) from April 2016 to July 2017.
Results
Group Characteristics
Sixty-five clinicians (mean age, 38.7 years; range, 23.0-64.0 years; 54 female [83%]; 29 New Zealand
European [44.6%], 11 Māori [16.9%], 6 Pacific [9.2%], 2 Asian [3.1%], and 17 other 17 [26.2%],
including 5 British, 4 American, and 3 South African) were recruited and randomized to receive
MATCH training (32 clinicians) or to deliver UC (33 clinicians). They were balanced with regard to age,
sex, and ethnicity.
Clinicians included 19 nurses trained in mental health (29.2%), 19 social workers (29.2%), 12
clinical psychologists (18.5%), 11 occupational therapists (16.9%), and 4 other clinicians (6.2%). They
had been in their current CAMHS roles for a mean (SD) of 3.5 (3.3) years (range, <3 months to 15
years). Overall clinical practice experience ranged from less than 1 year to 40 years (mean [SD], 11.4
[9.4] years). A similar percentage between groups had previously received training in relevant ESTs,
such as cognitive behavioral therapy or parent management training (MATCH, 12 clinicians [38%];
UC, 11 clinicians [33%]) and had at least 10 years postqualification practice (MATCH, 15 clinicians
[47%]; UC, 15 clinicians [45%]).
Two hundred six young people (mean age, 11.2 years; range 7.0-14.0 years; 122 female [61%])
(Table 1), were recruited and randomized, with 6 young people (5 fromMATCH, 1 from UC) leaving
the study before treatment began or any data were collected. Outcome data for at least 2 time points
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were available for the remaining 200 participants (97%), and 164 participants (80%) completed the
3-month follow-up assessment (Figure).
The 2 groups of youth participants (MATCH and UC) were balanced with regard to age, sex, and
ethnicity (Table 1). The ethnic make-up was similar to the general New Zealand population, apart
from an underrepresentation of Asian people (Table 1 and Table 2; eTable 1 in Supplement 2).
Clinical Outcomes
There were no significant differences between groups on the primary outcomemeasure, the
trajectory of change for total difficulties on the BPM as reported by parents (mean [SE] slope, –1.04
[0.14] and 1-year change of −6.12 in theMATCH group vs –1.04 [0.10] and 1-year change of −6.17 in the
Table 1. Baseline Characteristics by Treatment Group
Characteristic
Participants, No. (%)
MATCH (n = 97) Usual care (n = 103)
Age at study entry, mean (SD), y 10.9 (2.3) 11.3 (2.4)
Sex
Female 59 (60.8) 63 (61.2)
Male 38 (39.2) 40 (38.8)
Ethnicity (total response)a
New Zealand European or European 84 (86.6) 91 (88.3)
Māori 16 (16.5) 21 (20.4)
Pacific 10 (10.3) 9 (8.7)
Asian 3 (3.1) 3 (2.9)
Otherb 3 (3.1) 2 (1.9)
Previous use of mental health services?
Yes 30 (30.9) 48 (46.6)
No 64 (66.0) 53 (51.5)
Missing data 3 (3.1) 2 (1.9)
Service type
Mainstream child and adolescent mental health services 85 (87.6) 90 (87.4)
Kaupapa Māori Services 6 (6.2) 6 (5.8)
Pasifika Services 6 (6.2) 7 (6.8)
Baseline Brief Problem Monitor, mean (SD), total score
(range 0-38)
Parent 17.9 (7.3) 16.0 (8.0)
Youth 13.5 (6.3) 13.8 (7.0)
Baseline Strengths and Difficulties Questionnaire, mean (SD),
total difficulties score (range 0-40)
Parent 18.9 (6.2) 18.1 (7.0)
Youth 16.6 (6.7) 16.9 (6.5)
Abbreviation: MATCH, Modular Approach to Therapy
for Children.
a Ethnicity is recorded as total response; therefore,
more than 1 ethnicity may be reported.
b Responses for other ethnicity were 1 Chilean, 1
Iranian, 1 Jamaican, and 2 not specified.
Figure. FlowDiagram of Youth Participants
206 Youths randomized
102 Youths allocated to MATCH
97
5
Received treatment
Withdrew prior to treatment
104 Youths allocated to usual care
103
1
Received treatment
Withdrew prior to treatment
83 Completed follow-up at discharge
14 Withdrew from study
76 Completed follow-up at 3 mo
98 Completed follow-up at discharge
5 Withdrew from study
88 Completed follow-up at 3 mo
97 Youths available for analysis 103 Youths available for analysis
MATCH indicates Modular Approach to Therapy for
Children.
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UC group; effect size, 0.00; 95% CI, – 0.27 to – 0.28; P = .96) and as reported by youths (mean [SE]
slope, –0.74 [0.15] and 1-year change of −4.35 in theMATCH group vs –0.73 [0.10] and 1-year change
of −4.32 in the UC group; effect size, −0.02; 95% CI, −0.30 to 0.26; P = .97) or any other clinical
outcomemeasure (Table 3). Both groups improved significantly, with effects maintained to 3
months of follow-up (eTable 2 in Supplement 2). Sensitivity analyses on the primary clinical outcome
showed that the result was not affected bymedication use at baseline (F1,183 = 0.248; P = .78), prior
relevant EST accreditation of the clinician (F1,183 = 0.296; P = .14), or study site (F1,184 = 0.483;
P = .94). There were also no significant differences in the per-protocol analysis on the primary clinical
outcome (72 participants in theMATCH group vs 84 participants in the UC group).
Table 2. Diagnoses by Category at Baseline by Treatment Group
Diagnosisa
MATCH Usual Care
Valid, % Participants, No. (%) Valid, % Participants, No. (%)
Depressive disorder 58 14 (24.1) 73 13 (17.8)
Anxiety disorder
or posttraumatic stress disorderb
61 30 (49.2) 76 49 (64.4)
Disruptive behavior disorderc 51 19 (37.2) 71 19 (26.7)
Otherd 53 7 (13.2) 74 12 (16.3)
Abbreviation: MATCH, Modular Approach to Therapy for Children.
a Diagnoses were made with the Development andWell-Being Assessment. The presence of disorder was defined as less
than 50% probability or 50% probability or more.
b Includes separation anxiety, specific phobia, social phobia, panic, agoraphobia, generalized anxiety, posttraumatic stress
disorder, and obsessive-compulsive disorder.
c Includes oppositional or conduct disorders.
d Includes autism spectrum disorder, tics, self-harm, bipolar disorder, hyperactivity, and anorexia or bulimia.
Table 3. Clinical Outcomes: Trajectories of Change by Treatment Groupa
Outcome
MATCH (n = 97) Usual care (n = 103)
Effect size (95% CI) P valueSlope, mean (SE) 1-Year change Slope, mean (SE) 1-Year change
BPM, total
Parent –1.04 (0.14) –6.12 –1.04 (0.10) –6.17 0.00 (–0.27 to 0.28) .96
Youth –0.74 (0.15) –4.35 –0.73 (0.10) –4.32 –0.02 (–0.30 to 0.26) .97
BPM, internalizing
Parent –0.66 (0.09) –3.87 –0.63 (0.07) –3.71 0.04 (–0.24 to 0.32) .78
Youth –0.46 (0.09) –2.71 –0.38 (0.06) –2.23 0.13 (–0.15 to 0.41) .37
BPM, externalizing
Parent –0.38 (0.08) –2.24 –0.41 (0.06) –2.42 –0.05 (–0.33 to 0.23) .72
Youth –0.27 (0.08) –1.62 –0.36 (0.05) –2.10 .30
SDQ, total difficulties
Parent –1.17 (0.15) –6.92 –1.17 (0.11) –6.88 0.01 (–0.27 to 0.29) .96
Youth –0.89 (0.16) –5.27 –1.09 (0.11) –6.46 –0.17 (–0.45 to 0.11) .22
SDQ, internalizing
Parent –0.70 (0.11) –4.11 –0.73 (0.07) –4.33 –0.05 (–0.33 to 0.23) .72
Youth –0.50 (0.10) –2.92 –0.59 (0.07) –3.48 –0.14 (–0.42 to 0.14) .33
SDQ, externalizing
Parent –0.46 (0.08) –2.70 –0.42 (0.06) –2.50 0.06 (–0.22 to 0.34) .69
Youth –0.38 (0.10) –2.25 –0.49 (0.07) –2.90 –0.16 (–0.44 to 0.12) .26
Top problems assessment
Parent –0.85 (0.09) –5.03 –0.81 (0.06) –4.77 0.07 (–0.21 to 0.35) .61
Youth –0.94 (0.10) –5.56 –0.82 (0.07) –4.84 0.17 (–0.11 to 0.45) .24
Abbreviations: BPM, Brief ProblemMonitor; MATCH, Modular Approach to Therapy for Children; SDQ, Strengths and Difficulties Questionnaire.
a The slope is the estimate of the change in scale score per log day, and the 1-year change is the estimate of the change in scale score 1 year after the initial assessment. The primary
clinical outcomewas the trajectory of change of parent BPM.
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There were no significant differences between groups in the number of diagnoses from before
to after treatment (eTable 3 in Supplement 2). Prescription ofmedications for psychiatric conditions
did not differ between treatment groups at baseline or during therapy (eTable 4 in Supplement 2).
Delivery of EST
EST content adherence was significantly higher in theMATCH group (mean [SD] level of adherence,
80.0% [20.0%] for 58 coded sessions) than in the UC group (mean [SD] level of adherence, 57.0%
[32.0%] for 51 coded sessions) (F1,108 = 23.0; P < .001). Therapist competence ratings in delivery of
EST content were also significantly higher in the MATCH group (mean [SD], 2.30 [0.57]) than in the
UC group (mean [SD], 1.75 [0.50]) (F1,108 = 8.0; P = .001), with both adherence and competence
correspondingmost closely to an adequate but not optimal rating.10 The second round of coding
showed almost identical findings, with greater adherence in theMATCH group (58 participants;
mean [SD] level of adherence, 81.0% [22.1%]) than in the UC group (42 participants; mean [SD] level
of adherence, 56.0% [30.2%]) (F1,76 = 10.7; P = .002) and greater therapist competence in the
MATCH group (mean [SD] rating, 2.25 [0.62]) compared with the UC group (mean [SD] rating, 1.76
[0.64]) (F1,79 = 9.1; P = .003).
Efficiency of Service Delivery
Participants receiving MATCH attended significantly more therapy sessions than did participants in
the UC group (mean [SD], 13.4 [8.4] sessions vs 10.7 [7.7] sessions; F1,190 = 5.6; P = .02). However,
there were no significant differences in total face-to-face clinician time (mean [SD], 806 [527]
minutes in theMATCH group vs 677 [539]minutes in the UC group) or the overall duration of therapy
(mean [SD], 167 [107] days in theMATCH group vs 159 [107] days in the UC group) (Table 4).
SatisfactionWith Treatment
MATCH therapists were significantlymore satisfiedwith the treatment they had provided (mean [SD]
Therapist Satisfaction Index total scores, 4.0 [0.6] forMATCHdelivered to 79 participants vs 3.7 [0.6]
for UC delivered to 88 participants; F1,162 = 9.567; P = .002). Parent-rated and youth-rated total
satisfaction scores (maximum of 32 and 20, respectively) were high and not significantly different
between treatment groups (mean [SD] scores for parents, 25.7 [6.5] for MATCH vs 24.3 [7.3] for UC;
F1,170 = 1.780; P = .19; mean [SD] scores for youth, 16.4 [3.7] for MATCH vs 15.5 [4.2] for UC;
F1,158 = 2.076; P = .16).
Harms
There were no significant group differences in terms of serious andmoderate adverse events
(eTable 5 in Supplement 2). Initial treatment focus by group is shown in eTable 6 in Supplement 2.
Discussion
Training in MATCH resulted in significantly improved delivery of ESTs by clinicians, and the trajectory
of change in clinical outcomes resembled that found in other trials of MATCH.6,7 However, the
Table 4. Service Delivery Outcomes by Treatment Group
Outcome
MATCH (n = 97) Usual care (n = 103)
Effect size P ValueValid, % Mean (SD) Valid, % Mean (SD)
Clinician time, min 91 806 (527) 99 677 (539) 0.24 .10
Duration of contact, d 90 167 (107) 100 159 (107) 0.07 .61
Attended therapy sessions, No. 92 13.4 (8.4) 100 10.7 (7.7) 0.34 .02
Missed therapy sessions, No. 92 2.7 (3.0) 100 2.2 (3.4) 0.16 .28
Abbreviation: MATCH, Modular Approach to Therapy for Children.
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increased delivery of EST did not translate into improved clinical outcomes or efficiency. Young
people in both treatment groups improved similarly at discharge andmaintained this improvement
at 3 months’ follow-up. Effects were not moderated by individual services, clinician training,
medication use, or initial focus of treatment.
In 2 previous RCTs,6,7MATCH improved clinical outcomes and service efficiency, increasedEST
use comparedwithUC, and increaseduse of standardmanual-basedbehavioral and cognitive behav-
ioral therapy.7 It is notable that similar clinical changewas achieved in our studydespite fewer therapy
sessions and shorter duration than theprevious studies. Our studywas adequately powered andhad
more participants per group (200participants across 2 groups) than the other 2 studies,with 174par-
ticipants across 3 groups7 and 138participants across 2 groups.6 The training andweekly consultation
in all 3 studieswas providedby experts from thedevelopers’ team.Despite the use of group rather than
individual consultation, the delivery of EST (80.0%adherence in the present study comparedwith
83% in a previous study7) and the trajectory of clinical change in theMATCHgroup (−1.04 in the current
study comparedwith −0.94 in a previous study7)was as good as that achieved in the first trial of
MATCH.7 Thepopulations studied, clinical severity and context, andmeasures used in the 3 studies
were very similar. Themain difference between the studies lies in the extent of ESTuse in theUC
groups,whichwas 7% to8% inbothprevious studies6,7 comparedwith 57.0% in this study. In addition,
the trajectory of change in ourUCgroupwas equivalent to that in theMATCHgroup, in contrast to the
flatter trajectory inUC in the other 2 studies.6,7 An additional RCT comparingMATCHwithUChas re-
cently beenpublished21 and founddelivery rates of ESTof 67% forMATCHclinicians and27% forUC
clinicians, but therewere nodifferences betweenMATCHandUC for any clinicalmeasure. Perhaps
57.0%adherence to ESTs results in clinical outcomes similar to those for 80.0%adherence,whereas
7% to8%, as reported in theUS,6,7 does not. Themost recent trial ofMATCH22 also showedMATCH
clinicians providing higher levels of EST thanUCbut nodifferences in clinical outcomes.
Training inMATCH is consistently associatedwith improved levels of EST delivered, whereas the
variation in level of EST provided in UC across the 4 RCTs is marked.We considered the possibility of
contamination betweenMATCH and UC, with UC clinicians learning MATCH techniques through
teammeetings that are the norm in New Zealand. However, case discussions in teammeetings are
not detailed, and measures to protect against contamination in the current study were identical to
those in previous studies.6,7 The intensive monitoring involved in this study that may have improved
UC is also common to all studies, and so is unlikely to explain the differences. The efforts undertaken
to upskill the workforce through training in individual ESTs over the last 2 decades may have been
successful in improving UC in New Zealand.
Strengths and Limitations
Strengths of this study include themultisite clinical settings to maximize generalizability,
measurement of adverse events and clinical changes, allocation concealment, and blinded
assessments and analyses.9 Limitations include the underrepresentation of Asian young people, the
single-blind nature of the study, and the low percentage of Development andWell-Being Assessment
completion. The ICC ratings for the coding of ESTs were lower than wewould have liked. There was
no clear pattern of disagreement, although the sample of sessions used for coding fidelity, which was
appropriate for assessing overall intercoder reliability of the systemwithin New Zealand and
between New Zealand and US coders, was not large enough to domore fine-grained analyses.
Conclusions
These findings suggest that a brief 5-day training in MATCH resulted in a significant increase in the
delivery of ESTs. The lack of change in clinical outcome in our study despite a significant change in
delivery of ESTs and in contrast to previous studies may be partly explained by the high level of EST
delivered by UC clinicians. The question of how EST fidelity is related to clinical outcomes, and the
part played by nonspecific factors such as warmth and empathy, warrants further attention.
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